--KLA Keeps Quarterly Cash Dividend at $1.45 a Share, Payable on Sept. 3 to Shareholders on Aug. 15-March 2024-www.financetom.com

--KLA Keeps Quarterly Cash Dividend at $1.45 a Share, Payable on Sept. 3 to Shareholders on Aug. 15

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--KLA Keeps Quarterly Cash Dividend at $1.45 a Share, Payable on Sept. 3 to Shareholders on Aug. 15

Aug 1, 2024 2:27 PM

04:59 PM EDT, 08/01/2024 (MT Newswires) --

Price: 752.00, Change: -4.14, Percent Change: -0.55

Previous page： Advanced Biomed Prices 1.6 Million Shares to Raise $6.6 Million in IPO Next page： Update: Macy's Fiscal Q4 Adjusted Earnings, Revenue Decline; Fiscal 2025 Outlook Issued

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Advanced Biomed Prices 1.6 Million Shares to Raise $6.6 Million in IPO

Mar 6, 2025

09:28 AM EST, 03/06/2025 (MT Newswires) -- Advanced Biomed (ADVB) said Thursday it priced its initial public offering of 1.6 million shares at $4 per share, for expected gross proceeds of about $6.6 million. The shares have been approved for listing on Nasdaq and are expected to start trading on Thursday under the ticker ADVB, the company said. Underwriters have...

Update: Macy's Fiscal Q4 Adjusted Earnings, Revenue Decline; Fiscal 2025 Outlook Issued

Mar 6, 2025

09:48 AM EST, 03/06/2025 (MT Newswires) -- (Updates to add the company's share buyback plans and recent stock price movement in the last two paragraphs.) Macy's (M) reported fiscal Q4 adjusted earnings Thursday of $1.80 per diluted share, down from $2.24 a year earlier. Analysts polled by FactSet expected $1.54. Revenue for the quarter ended Feb. 1 was $8.01 billion,...

--MFA Financial Raises Quarterly Dividend to $0.36 a Share From $0.35, Payable April 30 to Shareholders of Record on March 31

Mar 6, 2025

09:50 AM EST, 03/06/2025 (MT Newswires) -- Price: 10.82, Change: +0.18, Percent Change: +1.74 ...

Arrowhead Pharmaceuticals Presents Data on Two Clinical-Stage Candidates for Obesity Treatment

Mar 6, 2025

09:48 AM EST, 03/06/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Thursday it has presented preclinical data supporting two RNA-interference-based investigational therapeutics it is developing, with the potential to reduce body weight and fat mass and preserve lean muscle mass compared with currently approved obesity therapies. Data from its ARO-INHBE candidate preclinical results showed a 19% suppression in...